Penpulimab in Combination With Cetuximab as First-line Treatment in R/M SCCHN

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

China

Department of radiotherapy,The First Bethune Hospital of Jilin University, Changchun, Jilin

Department of Radiotherapy, Eye & ENT Hospital of Fudan University, Shanghai